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ABSTRACT 
Metabolic effects of growth hormone (GH) therapy in short children have not been clearly 
established owing to the previous lack of controlled trials studying the metabolic outcome in 
response to different GH doses despite the known effects of GH on insulin sensitivity, lipid 
profile, and body composition. It has previously been shown that individualized GH doses 
during catch-up growth significantly reduce the proportion of unexpectedly good and poor 
responders around a predefined individual growth target in short prepubertal children. In the 
research on which this thesis is based, 87 prepubertal children were treated with six different 
GH doses, individually chosen according to a prediction model of GH sensitivity regarding 
linear bone growth. 
The first hypothesis was that the variance of the metabolic response during individualized 
GH treatment would be reduced. This was confirmed: individualized GH dosing during catch-
up growth reduced the variance in insulin and HOMA by 34.2 % and 38.9 %, respectively 
(Paper I).  
This led to the second hypothesis that metabolic responsiveness to GH treatment partly 
parallels and partly dissociates from the longitudinal growth response. This too was 
confirmed: a GH dose-dependent anabolic component was identified in contrast to a dose-
independent lipolytic component (Papers I and II). This finding raised the question of whether 
different thresholds would achieve certain metabolic effects, such as anabolic effects, 
lipolytic effects, and glucose metabolism. 
A pharmaco-proteomic approach was introduced in order to identify previous unknown 
biomarkers to predict metabolic responses to GH treatment as well as to investigate the 
physiology of GH (Papers III and IV). These results have been published recently, showing 
dissociations between GH-mediated longitudinal bone growth and bone mineralization and 
thereby confirming the second hypothesis named above (Paper III). 
The third hypothesis was that patients with and without classical GH deficiency (GHD) had 
correspondingly different thresholds of responsiveness to GH treatment among different 
metabolic functions. The data confirmed the hypothesis and, moreover, increasing effective 
GH doses were needed to achieve specific metabolic effects (Paper V). 
This research provides further evidence of the benefits of individualized GH dosing in order 
to maintain metabolic functions within age-adjusted reference values and to normalize body 
composition. In the long term, this might minimize metabolic and cardiovascular risk factors 
in children suffering from GHD or reduced GH responsiveness.  
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